Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
暂无分享,去创建一个
S. Melquist | D. Neary | B. Boeve | H. Feldman | D. Mann | S. Rollinson | A. Sadovnick | J. Snowden | M. Hutton | A. Richardson | I. Mackenzie | J. Gass | M. Baker | S. Pickering-Brown | J. Adamson | E. McGowan | Dennis Dickson | Z. Berger | R. Crook | C. Zehr | J. Eriksen | C. Dickey | A. Cannon | E. Dwosh | C. Lindholm | R. Rademakers | Todd Robinson | Dennis W. Dickson | A. Sadovnick
[1] C. Duijn,et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 , 2006, Nature.
[2] C. van Broeckhoven,et al. A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. , 2006, Brain : a journal of neurology.
[3] S. Melquist,et al. A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. , 2006, Brain : a journal of neurology.
[4] S. Ennis,et al. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis , 2006, Nature Genetics.
[5] I. Mackenzie,et al. Ubiquitin Immunohistochemistry Suggests Classic Motor Neuron Disease, Motor Neuron Disease With Dementia, and Frontotemporal Dementia of the Motor Neuron Disease Type Represent a Clinicopathologic Spectrum , 2005, Journal of neuropathology and experimental neurology.
[6] C. van Broeckhoven,et al. Genomic architecture of human 17q21 linked to frontotemporal dementia uncovers a highly homologous family of low-copy repeats in the tau region. , 2005, Human molecular genetics.
[7] J. Cummings,et al. Genotype — Proteotype — Phenotype Relationships in Neurodegenerative Diseases , 2005 .
[8] G. Serrero,et al. PC cell-derived growth factor (PCDGF/GP88, progranulin) stimulates migration, invasiveness and VEGF expression in breast cancer cells. , 2004, Carcinogenesis.
[9] H. Feldman,et al. Neuronal Intranuclear Inclusions Distinguish Familial FTD-MND Type from Sporadic Cases , 2004, Dementia and Geriatric Cognitive Disorders.
[10] D. Swaab,et al. Alzheimer’s disease and NGF signaling , 2004, Journal of Neural Transmission.
[11] L. Maquat. Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics , 2004, Nature Reviews Molecular Cell Biology.
[12] Zhiheng He,et al. Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis , 2003, Journal of Molecular Medicine.
[13] C. H. Ong,et al. Progranulin is a mediator of the wound response , 2003, Nature Medicine.
[14] L. Manuelidis,et al. Unique inflammatory RNA profiles of microglia in Creutzfeldt–Jakob disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[15] M. Spillantini,et al. Tau gene mutations: dissecting the pathogenesis of FTDP-17. , 2002, Trends in molecular medicine.
[16] C. Duijn,et al. Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval , 2002, Molecular Psychiatry.
[17] J. Trojanowski,et al. Update on the Neuropathological Diagnosis of Frontotemporal Dementias , 2001, Journal of neuropathology and experimental neurology.
[18] W. Kamphorst,et al. Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. , 2001, Brain : a journal of neurology.
[19] A. Malaspina,et al. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays , 2001, Journal of neurochemistry.
[20] G. Serrero,et al. Mediation of estrogen mitogenic effect in human breast cancer MCF-7 cells by PC-cell-derived growth factor (PCDGF/granulin precursor). , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[21] D. Neary,et al. Classification and Description of Frontotemporal Dementias , 2000, Annals of the New York Academy of Sciences.
[22] A. Bateman,et al. Cellular Localization of Gene Expression for Progranulin , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[23] N. Berardi,et al. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice , 2000 .
[24] T D Bird,et al. Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions , 2000, Neurology.
[25] P. Godeau. [Consensus conference]. , 2000, La Revue de medecine interne.
[26] D. Geschwind,et al. Inheritance of frontotemporal dementia. , 1999, Archives of neurology.
[27] Ronald C. Petersen,et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17 , 1998, Nature.
[28] N. Craddock,et al. Hereditary dysphasic disinhibition dementia A frontotemporal dementia linked to 17 q21‐‐22 , 1998, Neurology.
[29] L. Lannfelt,et al. Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12-21. , 1997, American journal of medical genetics.
[30] N L Foster,et al. Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference , 1997, Annals of neurology.
[31] S. M. Sumi,et al. Chromosome 17 and hereditary dementia , 1997, Neurology.
[32] Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. , 1994, Journal of neurology, neurosurgery, and psychiatry.